adenosine monophosphate has been researched along with ramipril in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhattacharya, SK; Boehm, M; Borzilleri, KA; Brown, JA; Calabrese, M; Cameron, KO; Caspers, NL; Cokorinos, E; Conn, EL; Dowling, MS; Edmonds, DJ; Eng, H; Fernando, DP; Frisbie, R; Hepworth, D; Kalgutkar, AS; Kung, DW; Kurumbail, RG; Landro, J; Mao, Y; Miller, R; Rajamohan, F; Reyes, AR; Rose, CR; Ryder, T; Salatto, CT; Shavnya, A; Smith, AC; Tu, M; Ward, J; Withka, JM; Wolford, AC; Xiao, J | 1 |
1 other study(ies) available for adenosine monophosphate and ramipril
| Article | Year |
|---|---|
Discovery and Preclinical Characterization of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577), a Direct Activator of Adenosine Monophosphate-activated Protein Kinase (AMPK), for the Potential Treatment of Diabetic Neph
Topics: Administration, Oral; Adsorption; AMP-Activated Protein Kinases; Animals; Crystallography, X-Ray; Diabetic Nephropathies; Dogs; Enzyme Activators; High-Throughput Screening Assays; Humans; Indazoles; Indoles; Injections, Intravenous; Macaca fascicularis; Male; Models, Molecular; Protein Conformation; Rats | 2016 |